RT Journal Article SR Electronic A1 Mosley, Mary T1 RDN: Its Current Place in the Treatment of Resistant Hypertension JF MD Conference Express YR 2015 FD SAGE Publications VO 14 IS 16 SP 16 OP 17 DO 10.1177/155989771416013 UL http://mdc.sagepub.com/content/14/16/16.abstract AB Renal denervation is a promising strategy to treat true treatment-resistant hypertension. However, careful patient selection is required, by a cardiac team using well-defined criteria. Renal denervation should only be performed in an experienced catheterization laboratory performing at least 14 ablations a year. Promising results have been obtained with new ablation devices.